TY  - JOUR
A1  - Schneider-Schaulies, Sibylle
A1  - Schumacher, Fabian
A1  - Wigger, Dominik
A1  - Schöl, Marie
A1  - Waghmare, Trushnal
A1  - Schlegel, Jan
A1  - Seibel, Jürgen
A1  - Kleuser, Burkhard
T1  - Sphingolipids: effectors and Achilles heals in viral infections?
JF  - Cells
N2  - As viruses are obligatory intracellular parasites, any step during their life cycle strictly depends on successful interaction with their particular host cells. In particular, their interaction with cellular membranes is of crucial importance for most steps in the viral replication cycle. Such interactions are initiated by uptake of viral particles and subsequent trafficking to intracellular compartments to access their replication compartments which provide a spatially confined environment concentrating viral and cellular components, and subsequently, employ cellular membranes for assembly and exit of viral progeny. The ability of viruses to actively modulate lipid composition such as sphingolipids (SLs) is essential for successful completion of the viral life cycle. In addition to their structural and biophysical properties of cellular membranes, some sphingolipid (SL) species are bioactive and as such, take part in cellular signaling processes involved in regulating viral replication. It is especially due to the progress made in tools to study accumulation and dynamics of SLs, which visualize their compartmentalization and identify interaction partners at a cellular level, as well as the availability of genetic knockout systems, that the role of particular SL species in the viral replication process can be analyzed and, most importantly, be explored as targets for therapeutic intervention.
KW  - glycosphingolipids
KW  - ceramides
KW  - sphingosine 1-phosphate
KW  - sphingomyelinase
KW  - HIV
KW  - SARS-CoV-2
KW  - measles
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-245151
SN  - 2073-4409
VL  - 10
IS  - 9
ER  -